ARCHIVES

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 43 | November 10, 1989

Download PDF Visit The Full Archive

Related Articles

Big Get Bigger, Litton Primate Contract Renewed

September 19, 1975

NCI To Place 20% Cap On Grant Renewal Increases.

May 25, 2001

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

Exercisers May Have Higher Breast Cancer Survival

October 27, 2006

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996

In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril

May 30, 1975